Endocyte Offers Preclinical Data for App of SMDC Technology in CAR T Cell Therapy in Late-Breaking Abstract at AACR Meeting

By: via Benzinga
Endocyte, Inc. (NASDAQ: ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.